Back

Development and validation of a Trans-Ancestry polygenic risk score for Type 1 Diabetes

2025-06-09 endocrinology Title + abstract only
View on medRxiv
Show abstract

ObjectivesThe high heritability of type 1 diabetes has enabled the development of polygenic risk scores (PRS) as disease risk screening tools. PRS can identify individuals at the highest genetic risk in a population, who can benefit from autoantibody and metabolic surveillance, to avoid ketoacidosis at diagnosis and access preventive therapies. However, PRS for type 1 diabetes developed from European data perform less well in non-European ancestries. We aimed to develop a PRS with comparable per...

Predicted journal destinations